Neuronal grafts for Huntington's disease

Article metrics

Embryonic striatal neurons transplanted into marmoset brains become integrated into host tissue and induce functional recovery in a primate model of Huntington's disease (pages 727–729).

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Kendall, A.L. et al. Functional integration of striatal allografts in a primate model of Huntington's disease. Nature Med. 4, 727–729 (1998).

  2. 2

    Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72, 971–983 (1993).

  3. 3

    Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387–392 (1993).

  4. 4

    Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398–403 (1993).

  5. 5

    MacDonald, M.E. & Gusella, J.F. Huntington's disease: Translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638–643 (1996).

  6. 6

    Strong, T.V. et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5, 259–265 (1993).

  7. 7

    Ferrante, R.J. et al. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 9, 3052–3063 (1997).

  8. 8

    Mangiarini, L. et al. Exon 1 of the Huntington's disease gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).

  9. 9

    Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 (1997).

  10. 10

    DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).

  11. 11

    Björklund, A. & Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177, 555–560 (1979).

  12. 12

    Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574–577 (1990).

  13. 13

    Dunnett, S.B. & Svendsen, C.N. Huntington's disease: animal models and transplantation repair. Curr. Opin. Neurobiol. 3, 790–796 (1993).

  14. 14

    Nakao, N., Grasbon-Frodl, E.M., Widner, H. & Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74, 959–970 (1996)

  15. 15

    Kopyov, O.V., Jacques, S., Lieberman, A., Duma, C.M. & Eagle, K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149, 97–108 (1998).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Horellou, P., Mallet, J. Neuronal grafts for Huntington's disease. Nat Med 4, 669–670 (1998) doi:10.1038/nm0698-669

Download citation

Further reading